These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27316790)

  • 41. The role of corticotropin-releasing factor in drug addiction.
    Sarnyai Z; Shaham Y; Heinrichs SC
    Pharmacol Rev; 2001 Jun; 53(2):209-43. PubMed ID: 11356984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders.
    Owens MJ; Vargas MA; Nemeroff CB
    J Psychiatr Res; 1993; 27 Suppl 1():209-20. PubMed ID: 8145178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The hypothalamopituitary-adrenal axis and alcohol preference.
    O'Callaghan MJ; Croft AP; Jacquot C; Little HJ
    Brain Res Bull; 2005 Dec; 68(3):171-8. PubMed ID: 16325017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis.
    Lowery EG; Spanos M; Navarro M; Lyons AM; Hodge CW; Thiele TE
    Neuropsychopharmacology; 2010 May; 35(6):1241-52. PubMed ID: 20130533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
    Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N; Kitamura K
    Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prenatal exposure to interleukin-6 results in hypertension and increased hypothalamic-pituitary-adrenal axis activity in adult rats.
    Samuelsson AM; Ohrn I; Dahlgren J; Eriksson E; Angelin B; Folkow B; Holmäng A
    Endocrinology; 2004 Nov; 145(11):4897-911. PubMed ID: 15284195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal.
    Martínez-Laorden E; García-Carmona JA; Baroja-Mazo A; Romecín P; Atucha NM; Milanés MV; Laorden ML
    Br J Pharmacol; 2014 Feb; 171(3):688-700. PubMed ID: 24490859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats.
    Lê AD; Harding S; Juzytsch W; Watchus J; Shalev U; Shaham Y
    Psychopharmacology (Berl); 2000 Jun; 150(3):317-24. PubMed ID: 10923760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors.
    Rivier CL; Grigoriadis DE; Rivier JE
    Endocrinology; 2003 Jun; 144(6):2396-403. PubMed ID: 12746300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of hesperidin on behavior and HPA axis of rat model of chronic stress-induced depression].
    Cai L; Li R; Wu QQ; Wu TN
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):229-33. PubMed ID: 23672047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blocking corticotropin-releasing factor-2 receptors, but not corticotropin-releasing factor-1 receptors or glucocorticoid feedback, disrupts the development of conditioned defeat.
    Cooper MA; Huhman KL
    Physiol Behav; 2010 Nov; 101(4):527-32. PubMed ID: 20705077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: role of corticotropin-releasing factor (CRF) 1 receptor.
    Navarro-Zaragoza J; Martínez-Laorden E; Mora L; Hidalgo J; Milanés MV; Laorden ML
    Toxicol Appl Pharmacol; 2014 Feb; 275(1):28-35. PubMed ID: 24398105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release--the impacts on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z; Csabafi K; Jászberényi M; Telegdy G
    Neurochem Int; 2012 Mar; 60(4):350-4. PubMed ID: 22306347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute stress-induced sensitization of the pituitary-adrenal response to heterotypic stressors: independence of glucocorticoid release and activation of CRH1 receptors.
    Belda X; Daviu N; Nadal R; Armario A
    Horm Behav; 2012 Sep; 62(4):515-24. PubMed ID: 22986335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of CRF
    Tanaka M; Tomimatsu Y; Sakimura K; Ootani Y; Sako Y; Kojima T; Aso K; Yano T; Hirai K
    Peptides; 2017 Sep; 95():40-50. PubMed ID: 28689880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of chronic alcohol consumption and withdrawal on the response of the male and female hypothalamic-pituitary-adrenal axis to acute immune stress.
    Silva SM; Madeira MD
    Brain Res; 2012 Mar; 1444():27-37. PubMed ID: 22341871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased activity of the hypothalamic-pituitary-adrenal axis of rats exposed to alcohol in utero: role of altered pituitary and hypothalamic function.
    Lee S; Schmidt D; Tilders F; Rivier C
    Mol Cell Neurosci; 2000 Oct; 16(4):515-28. PubMed ID: 11085885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of chronic social stress on neuroendocrine responsiveness to challenge with ethanol, dexamethasone and corticotropin-releasing hormone.
    Pohorecky LA; Baumann MH; Benjamin D
    Neuroendocrinology; 2004; 80(5):332-42. PubMed ID: 15692218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The involvement of nitric oxide and prostaglandins in the cholinergic stimulation of hypothalamie-pituitary-adrenal response during crowding stress.
    Bugajski AJ; Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2006 Sep; 57(3):463-77. PubMed ID: 17033098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.